Literature DB >> 23769696

Influence of trans fat and omega-3 on the preference of psychostimulant drugs in the first generation of young rats.

Fábio T Kuhn1, Karine Roversi, Caren T D Antoniazzi, Camila S Pase, Fabíola Trevizol, Raquel C S Barcelos, Verônica T Dias, Katiane Roversi, Nardeli Boufleur, Dalila M Benvegnú, Jaqueline Piccolo, Tatiana Emanuelli, Marilise E Bürger.   

Abstract

The current Western diet often provides considerable amounts of saturated and trans fatty acids (TFA), whose incorporation into neuronal membranes has been implicated in changes of brain neurochemical functions. Such influence has caused concerns due to precipitation of neuropsychiatric disorders, whose data are still unclear. Here we evaluated the influence of different fats on preference parameters for amphetamine (AMPH): adolescent rats were orally supplemented with soybean oil (SO, rich in n-6 FA, which was considered an isocaloric control group), fish oil (FO, rich in n-3 FA) and hydrogenated vegetable fat (HVF, rich in saturated and trans FA) from weaning, which were born of dams supplemented with the same fat from pregnancy and lactation. AMPH preference, anxiety-like symptoms and locomotor index were evaluated in conditioned place preference (CPP), elevated plus maze (EPM) and open-field (OF), respectively, while brain oxidative status was determined in cortex, striatum and hippocampus. HVF increased AMPH-CPP and was associated with withdrawal signs, as observed by increased anxiety-like symptoms. Moreover, SO and FO were not associated with AMPH preference, but only FO-supplemented rats did not show any anxiety-like symptoms or increased locomotion. FO supplementation was related to lower oxidative damages to proteins and increased CAT activity in striatum and hippocampus, as well as increased GSH levels in blood, while HVF was related to increased oxidative status. In conclusion, our study showed the harmful influence of TFA on AMPH-CPP and drug craving symptoms, which can be related to dopaminergic neurotransmission.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AA; ADHD; AMPH; Addiction; Amphetamine; COX-2; CPP; DA; DHA; Drugs abuse; EFA; EPA; EPM; FA; FO; HVF; LA; LC-PUFA; NE; OF; Omega-3; PUFA; SO; TFA; Trans fatty acid; amphetamine; arachidonic acid; attention deficit hyperactivity disorder; conditioned place preference; cyclooxygenase-2; docosahexaenoic acid; dopamine; eicosapentaenoic acid; elevated plus maze; essential fatty acids; fatty acids; fish oil; hydrogenated vegetable fat; linoleic acid; long chain polyunsaturated fatty acids; norepinephrine; open field; polyunsaturated fatty acids; soybean oil; trans fatty acids

Mesh:

Substances:

Year:  2013        PMID: 23769696     DOI: 10.1016/j.pbb.2013.06.001

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

1.  Cross-Generational trans Fat Consumption Favors Self-Administration of Amphetamine and Changes Molecular Expressions of BDNF, DAT, and D1/D2 Receptors in the Cortex and Hippocampus of Rats.

Authors:  Fábio Teixeira Kuhn; Verônica Tironi Dias; Karine Roversi; Luciana Taschetto Vey; Daniele Leão de Freitas; Camila Simonetti Pase; Katiane Roversi; Juliana Cristina Veit; Tatiana Emanuelli; Marilise Escobar Bürger
Journal:  Neurotox Res       Date:  2015-07-19       Impact factor: 3.911

2.  Tactile Stimulation in Adult Rats Modulates Dopaminergic Molecular Parameters in the Nucleus accumbens Preventing Amphetamine Relapse.

Authors:  D R Rossato; H Z Rosa; J L O Rosa; L H Milanesi; V G Metz; L F D'Àvila; M E Burger
Journal:  Mol Neurobiol       Date:  2022-06-22       Impact factor: 5.682

3.  The Effect of High-Frequency Electrical Stimulation of Bilateral Nucleus Accumbens on the Behavior of Morphine-Induced Conditioned Place Preference Rats at Extinction and Reinstatement Phases.

Authors:  Chunhui Yang; Yiqing Qiu; Xiaowu Hu; Jianchun Chen; Yina Wu; Xi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-12       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.